Resultats globals: 57 registres trobats en 0.03 segons.
Articles, 30 registres trobats
Documents de recerca, 27 registres trobats
Fons personals i institucionals, 1 registres trobats
Articles 30 registres trobats  1 - 10següentfinal  anar al registre:
1.
9 p, 652.1 KB ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas / Castellana, Bàrbara (Institut d'Investigació Biomèdica Sant Pau) ; Escuin, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Peiró, Gloria (Hospital General Universitario de Alicante) ; Garcia Valdecasas, Bárbara (Universitat Autònoma de Barcelona) ; Vázquez, Tania (Institut d'Investigació Biomèdica Sant Pau) ; Pons, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Olabarria, Maitane (Institut d'Investigació Biomèdica Sant Pau) ; Barnadas i Molins, Agustí (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lerma Puertas, Enrique (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques)
The mechanism of progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) remains largely unknown. We compared gene expression in tumors with simultaneous DCIS and IDC to decipher how diverse proteins participate in the local invasive process. [...]
2012 - 10.7150/jca.4120
Journal of Cancer, Vol. 3, Núm. 1 (2012) , p. 175-183  
2.
12 p, 1.3 MB Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells / Patiño Padial, Tania (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ; Soriano Martín, Jorge (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ; Barrios, L. (Leonardo) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ; Ibáñez, Elena (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ; Nogués, C. (Carme) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia)
The use of micro- and nanodevices as multifunctional systems for biomedical applications has experienced an exponential growth during the past decades. Although a large number of studies have focused on the design and fabrication of new micro- and nanosystems capable of developing multiple functions, a deeper understanding of their interaction with cells is required. [...]
2015 - 10.1038/srep11371
Scientific Reports, Vol. 5 (June 2015) , art. 11371  
3.
11 p, 1.0 MB ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer / Cedó, Lidia (Institut d'Investigació Biomèdica Sant Pau) ; García León, Annabel (Institut d'Investigacions Biomèdiques Sant Pau) ; Baila Rueda, Lucía (Hospital Universitario Miguel Servet) ; Santos, David (Institut d'Investigacions Biomèdiques Sant Pau) ; Grijalva, Victor (University of California. Department of Medicine) ; Martínez Cignoni, Melanie Raquel (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Carbó, José María (Universitat de Barcelona) ; Metso, Jari (Minerva Foundation Institute for Medical Research) ; López Vilaró, Laura (Institut d'Investigacions Biomèdiques Sant Pau) ; Zorzano Olarte, Antonio (Institute for Research in Biomedicine) ; Valledor, Annabel F. (Universitat de Barcelona) ; Cenarro, Ana (Hospital Universitario Miguel Servet) ; Jauhiainen, Matti (Minerva Foundation Institute for Medical Research) ; Lerma Puertas, Enrique (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Fogelman, Alan M. (University of California. Department of Medicine) ; Reddy, Srinivasa T. (University of California. Department of Medicine) ; Escolà-Gil, Joan Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Blanco Vaca, Francisco (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. [...]
2016 - 10.1038/srep36387
Scientific Reports, Vol. 6 (November 2016) , art. 36387  
4.
14 p, 4.6 MB Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases / De Mattos-Arruda, Leticia (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Ng, Charlotte K. Y. (Department of Biomedicine, University of Basel, Basel, Switzerland) ; Piscuoglio, Salvatore (Institute of Pathology, University Hospital Basel) ; Gonzalez-Cao, Maria (Hospital Universitari Quirón Dexeus) ; Lim, Raymond S. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; De Filippo, Maria R. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Fusco, Nicola (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Schultheis, Anne M. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Ortiz, Carolina (Vall d'Hebron Institut d'Oncologia) ; Viteri, Santiago (Hospital Universitari Quirón Dexeus) ; Arias, Alexandra (Vall d'Hebron Institut d'Oncologia) ; Macedo, Gabriel S. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Oliveira, Mafalda (Vall d'Hebron Institut d'Oncologia) ; Gomez, Patricia (Vall d'Hebron Institut d'Oncologia) ; Teixidó, Cristina (Hospital Universitari Quirón Dexeus) ; Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Peg, Vicente (Vall d'Hebron Institut de Recerca) ; Saura, Cristina (Vall d'Hebron Institut d'Oncologia) ; Ramon y Cajal, Santiago (Vall d'Hebron Institut de Recerca) ; Tresserra Casas, Francesc (Hospital Universitari Quirón Dexeus) ; Weigelt, Britta (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Cortes, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Seoane Suárez, Joan (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Reis-Filho, Jorge S. (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)
Brain metastases constitute a challenge in the management of patients with HER2-positive breast cancer treated with anti-HER2 systemic therapies. Here we sought to define the repertoire of mutations private to or enriched for in HER2-positive brain metastases. [...]
2018 - 10.18632/oncotarget.25041
Oncotarget, Vol. 9 (april 2018) , p. 20617-20630  
5.
16 p, 352.3 KB Patient-centered care in breast cancer genetic clinics / Brédart, Anne (Univesité Paris Descartes) ; Anota, Amélie (Centre Hospitalier Régional Universitaire de Besançon) ; Dick, Julia (Cancer Center Cologne) ; Kuboth, Violetta (Cancer Center Cologne) ; Lareyre, Olivier (Institut Curie) ; De Pauw, Antoine (Institut Curie) ; Cano, Alejandra (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ; Stoppa-Lyonnet, Dominique (Institut Curie) ; Schmutzler, Rita (Cancer Center Cologne) ; Dolbeault, Sylvie (Centre de Recherche en Épidémiologie et Santé des Populations (CESP)) ; Kop, Jean-Luc (Université de Lorraine)
With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially leading to unmet psychosocial needs. We assessed psychosocial needs and correlates in women initiating testing for high genetic BC risk in clinics in France and Germany, and compared these results with data from a literature review. [...]
2018 - 10.3390/ijerph15020319
International Journal of Environmental Research and Public Health, Vol. 15 (february 2018)  
6.
23 p, 9.1 MB MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells / Sánchez-Cid, Lourdes (Instituto de Salud Carlos III. CIBER de Bioingeniería, Biomateriales y Nanomedicina) ; Pons, Mònica (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Lozano, Juan José (Instituto de Salud Carlos III. Centro de investigación biomédica en red. Enfermedades hepáticas y digestivas (CIBER-EHD)) ; Rubio, Nuria (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Guerra-Rebollo, Marta (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Soriano, Aroa (Vall d'Hebron Institut de Recerca (VHIR)) ; Paris-Coderch, Laia (Vall d'Hebron Institut de Recerca (VHIR)) ; Segura, Miquel F. (Vall d'Hebron Institut de Recerca (VHIR)) ; Fueyo, Raquel (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Arguimbau, Judit (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Zodda, Erika (Universitat de Barcelona. Departament de Bioquímica i Biologia molecular) ; Bermudo, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Alonso, Immaculada (Hospital Clínic de Barcelona. Departament d'Obstetrícia i Ginecologia) ; Caparrós, Xavier (Hospital Clínic de Barcelona. Departament d'Obstetrícia i Ginecologia) ; Cascante, Marta (Universitat de Barcelona. Departament de Bioquímica i Biologia molecular) ; Rafii, Arash (Weill Cornell Medical College. Education City (Ar-Rayyan, Qatar)) ; Kang, Yibin (Princeton University. Department of Molecular Biology) ; Martínez-Balbás, Marian (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Weiss, Stephen J. (University of Michigan. Life Sciences Institute) ; Blanco, Jerónimo (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Muñoz, Montserrat (Hospital Clínic de Barcelona. Departament d'Oncologia) ; Fernández, Pedro L. (Universitat de Barcelona. Facultat de Medicina) ; Thomson, Timothy M. (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Universitat Autònoma de Barcelona
MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. [...]
2017 - 10.18632/oncotarget.20698
Oncotarget, Vol. 8, Num. 48 (October 2017) , p. 83384-83406  
7.
12 p, 675.8 KB Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG / Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12  
8.
13 p, 2.7 MB Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state / Feijoo, Purificación (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Terradas Ill, Mariona (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Soler, David (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Domínguez, Daniel (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Tusell Padrós, Laura (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Genescà, A. (Anna) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Breast cancer is the most common malignant disease in women, but some basic questions remain in breast cancer biology. To answer these, several cell models were developed. Recently, the use of improved cell-culture conditions has enabled the development of a new primary cell model with certain luminal characteristics. [...]
2016 - 10.1186/s13058-015-0667-z
Breast Cancer Research : BCR, Vol. 18 (January 2016) , art. 7  
9.
12 p, 2.2 MB MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients / De Mattos-Arruda, Leticia (Institut d'Oncologia de la Vall Hebron) ; Bottai, Giulia (Oncology Experimental Therapeutics Unit. IRCCS Humanitas Clinical and Research Institute (Italy)) ; Nuciforo, Paolo Giovanni (Institut d'Oncologia de la Vall Hebron) ; Di Tommaso, Luca (Division of Pathology. IRCCS Humanitas Clinical and Research Institute (Italy)) ; Giovannetti, Elisa (University of Pisa. Cancer Pharmacology Laboratory. AIRC Start-Up Unit (Italy)) ; Peg, Vicente (Hospital Universitari Vall d'Hebron. Departament de Patologia) ; Losurdo, Agnese (Division of Oncology and Hematology. IRCCS Humanitas Clinical and Research Institute (Italy)) ; Pérez-Garcia, José (Institut d'Oncologia de la Vall Hebron) ; Masci, Giovanna (Division of Oncology and Hematology. IRCCS Humanitas Clinical and Research Institute (Italy)) ; Corsi, Fabio (University of Milan. Deparment of Clinical and Biomedical Sciences "Luigi Sacco" (Italy)) ; Cortés, Javier (Hospital Universitario Ramón y Cajal) ; Seoane Suárez, Joan (Institut d'Oncologia de la Vall Hebron) ; Calin, George A. (The University of Texas MD Anderson Cancer Center (USA)) ; Santarpia, Libero (Oncology Experimental Therapeutics Unit. IRCCS Humanitas Clinical and Research Institute (Italy)) ; Universitat Autònoma de Barcelona
Patients with primary HER2-positive breast cancer benefit from HER2-targeted therapies. Nevertheless, a significant proportion of these patients die of disease progression due to mechanisms of drug resistance. [...]
2015 - 10.18632/oncotarget.5495
Oncotarget, Vol. 6, Num. 35 (October 2015) , p. 37269-37280  
10.
10 p, 1.9 MB High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy / Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Thyparambil, Sheeno (OncoPlex Diagnostics. USA) ; Aura, Claudia (Vall d'Hebron Institut d'Oncologia) ; Garrido-Castro, Ana (Hospital Universitari Vall d'Hebron. Departament d'Oncologia) ; Vilaro, Marta (Vall d'Hebron Institut d'Oncologia) ; Peg, Vicente (Hospital Universitari Vall d'Hebron) ; Jimenez, José (Vall d'Hebron Institut d'Oncologia) ; Vicario, Rocio (Vall d'Hebron Institut d'Oncologia) ; Cecchi, Fabiola (OncoPlex Diagnostics. USA) ; Hoos, William (OncoPlex Diagnostics. USA) ; Burrows, Jon (OncoPlex Diagnostics. USA) ; Hembrough, Todd (OncoPlex Diagnostics. USA) ; Ferreres, Juan Carles (Hospital Universitari Vall d'Hebron) ; Perez-Garcia, José (Hospital Universitari Vall d'Hebron. Departament d'Oncologia) ; Arribas, Joaquín V. (Vicente) (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Cortes, Javier (Hospital Universitari Vall d'Hebron. Departament d'Oncologia) ; Scaltriti, Maurizio (Human Oncology & Pathogenesis Program (HOPP). Memorial Sloan-Kettering Cancer Center. USA) ; Universitat Autònoma de Barcelona
Introduction: Current methods to determine HER2 (human epidermal growth factor receptor 2) status are affected by reproducibility issues and do not reliably predict benefit from anti‐HER2 therapy. Quantitative measurement of HER2 may more accurately identify breast cancer (BC) patients who will respond to anti‐HER2 treatments. [...]
2016 - 10.1016/j.molonc.2015.09.002
Molecular Oncology, Vol. 10, núm 1 (January 2016) , p. 138-147  

Articles : 30 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 27 registres trobats  1 - 10següentfinal  anar al registre:
1.
1 p, 1.4 MB Design and engineering of trastuzumab emtansine production plant : part III, upstream, bioreactions and fermentation of the antitumorigenic agent Ansamitocin P3 / Puig Laborda, Víctor ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Graduat o Graduada en Biotecnologia [815]  
2.
1 p, 2.3 MB Design and engineering of trastuzumab emtansine production plant : part I, introduction to T-DM1 production process and upstream of monoclonal antibody trastuzumab / Salse Guiu, Laura ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Graduat o Graduada en Biotecnologia [815]  
3.
29 p, 724.4 KB Correlation Between Ultrasonography and Magnetic Resonance Imaging with Pathology-Measured Tumor Size in Women with Recently Diagnosed Breast Cancer. Optimizing tumor-size estimation with imaging techniques for higher precision / Brenner Anidjar, Rony-David ; Luna Tomás, Miguel-Ángel, dir. ; Universitat Autònoma de Barcelona. Facultat de Medicina
The use of Breast-MRI in surgical planning of breast cancer is a field of controversy due to its high sensitivity but low specificity, alongside with overestimation of tumor-size. It has been proven many factors contribute to this overestimation. [...]
El uso de Resonancia Magnética Mamaria (RMM) en la planificación pre-quirúrgica del cáncer de mama es controvertido dada la alta sensibilidad y baja especificidad, junto con la sobreestimación del tamaño tumoral. [...]

2017
Graduat o Graduada en Medicina [1192]  
4.
1 p, 942.9 KB The role of ALDHbr BCSCs as prognostic markers and therapeutic targets in breast cancer / Grima Reyes, Manuel ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Graduat o Graduada en Bioquímica [814]  
5.
1 p, 17.8 MB Proteomics application in breast cancer / Blanco Vega, Noemí ; Bassols Teixidó, Anna Maria, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Bioquímica [814]  
6.
1 p, 2.5 MB Anticancer prodrugs, the new way of using nanoparticles / Jiménez Giménez, Esther ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Bioquímica [814]  
7.
1 p, 5.4 MB MicroRNAs' role in epithelial-mesenchymal transition in breast cancer / Delowar Akther, Hossain ; Itarte, Emili, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Bioquímica [814]  
8.
1 p, 1.0 MB Breast cancer stem cells generated through the epithelial mesenchymal transition / Ibars Sillés, Patricia ; Itarte, Emili, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Bioquímica [814]  
9.
1 p, 8.1 MB Monoubiquitination linked to regulation transcriptional mechanism in breast cancer / Poch Coronel, John Jesús ; Roque Córdova, Alicia, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Bioquímica [814]  
10.
1 p, 2.7 MB Role of Trastuzumab in HER2+ breast cancer : importance of combined theraphy / Ceriol García-Jáudenes, Carlos ; Jiménez Altayó, Francesc, dir. (Universitat Autònoma de Barcelona.Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Ciències Biomèdiques [832]  

Documents de recerca : 27 registres trobats   1 - 10següentfinal  anar al registre:
Fons personals i institucionals 1 registres trobats  
1.
8 p, 330.9 KB Influence of the Dietary Polyunsaturation Level on Chicken Meat Quality: Lipid Oxidation / Cortinas Hernández, Lucía ; Barroeta Lajusticia, Ana Cristina (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Villaverde Haro, Cecilia ; Galobart i Cots, Jaume ; Guardiola, Francesc ; Baucells Sánchez, María Dolores (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments)
The present study was carried out to evaluate the influence of increasing amounts of dietary polyunsaturated fatty acids (PUFA) and α-tocopheryl acetate (α-TA) supplementation on lipid oxidation of raw and cooked thigh meat stored under refrigeration. [...]
2005
Poultry Science, Vol. 84 Núm. 1 (2005) , p. 48-55  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.